FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stuart Levy

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Douglas M Warner; Yingchun Xu; Qiwen Yang; Minjun Chen; Valérie Duval; Stuart B Levy
Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China.
Stuart B Levy; Bonnie M Marshall
Honeybees and tetracycline resistance.
Bonnie M Marshall; Eduardo Robleto; Theresa Dumont; Stuart B Levy
The frequency of antibiotic-resistant bacteria in homes differing in their use of surface antibacterial agents.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stuart Levy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Douglas M Warner; Yingchun Xu; Qiwen Yang; Minjun Chen; Valérie Duval; Stuart B Levy
Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China.
Antimicrobial agents and chemotherapy 2013;57(4):1935-7.
2013: Stuart B Levy; Bonnie M Marshall
Honeybees and tetracycline resistance.
mBio 2013;4(1):e00045-13.
2012: Bonnie M Marshall; Eduardo Robleto; Theresa Dumont; Stuart B Levy
The frequency of antibiotic-resistant bacteria in homes differing in their use of surface antibacterial agents.
Current microbiology 2012;65(4):407-15.
2012: Mark W Silby; Julie S Nicoll; Stuart B Levy
Regulation of polyphosphate kinase production by antisense RNA in Pseudomonas fluorescens Pf0-1.
Applied and environmental microbiology 2012;78(12):4533-7.
2012: Matthew D Mastropaolo; Julie S Nicoll; Mark W Silby; Stuart B Levy
Novel genes involved in Pseudomonas fluorescens Pf0-1 motility and biofilm formation.
Applied and environmental microbiology 2012;78(12):4318-29.
2011: Bonnie M Marshall; Stuart B Levy
Food animals and antimicrobials: impacts on human health.
Clinical microbiology reviews 2011;24(4):718-33.
2011: Laura M McMurry; Stuart B Levy
The periplasmic protein MppA is not involved in regulation of marA in Escherichia coli.
Antimicrobial agents and chemotherapy 2011;55(10):4939.
2011: Mark W Silby; Craig Winstanley; Scott A C Godfrey; Stuart B Levy; Robert W Jackson
Pseudomonas genomes: diverse and adaptable.
FEMS microbiology reviews 2011;35(4):652-80.
2011: Paolina Garbeva; Mark W Silby; Jos M Raaijmakers; Stuart B Levy; Wietse de Boer
Transcriptional and antagonistic responses of Pseudomonas fluorescens Pf0-1 to phylogenetically different bacterial competitors.
The ISME journal 2011;5(6):973-85.
2010: Lynne K Garrity-Ryan; Oak K Kim; Joan-Miquel Balada-Llasat; Victoria J Bartlett; Atul K Verma; Michael L Fisher; Cynthia Castillo; Warangkhana Songsungthong; S Ken Tanaka; Stuart B Levy; Joan Mecsas; Michael N Alekshun
Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model.
Infection and immunity 2010;78(11):4683-90.
2010: Laura M McMurry; Stuart B Levy
Evidence that regulatory protein MarA of Escherichia coli represses rob by steric hindrance.
Journal of bacteriology 2010;192(15):3977-82.
2010: Mark C Grier; Lynne K Garrity-Ryan; Victoria J Bartlett; Kevin A Klausner; Peter J Donovan; Caroline Dudley; Michael N Alekshun; S Ken Tanaka; Michael P Draper; Stuart B Levy; Oak K Kim
N-Hydroxybenzimidazole inhibitors of ExsA MAR transcription factor in Pseudomonas aeruginosa: In vitro anti-virulence activity and metabolic stability.
Bioorganic & medicinal chemistry letters 2010;20(11):3380-3.
2010: Cristian Ruiz; Stuart B Levy
Many chromosomal genes modulate MarA-mediated multidrug resistance in Escherichia coli.
Antimicrobial agents and chemotherapy 2010;54(5):2125-34.
2010: Francis Domain; Stuart B Levy
GyrA interacts with MarR to reduce repression of the marRAB operon in Escherichia coli.
Journal of bacteriology 2010;192(4):942-8.
2010: Douglas M Warner; Stuart B Levy
Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon.
Microbiology (Reading, England) 2010;156(Pt 2):570-8.
2010: Ida M Lister; Joan Mecsas; Stuart B Levy
Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis.
Infection and immunity 2010;78(1):364-71.
2009: Valérie Duval; Hervé Nicoloff; Stuart B Levy
Combined inactivation of lon and ycgE decreases multidrug susceptibility by reducing the amount of OmpF porin in Escherichia coli.
Antimicrobial agents and chemotherapy 2009;53(11):4944-8.
2009: Oak K Kim; Lynne K Garrity-Ryan; Victoria J Bartlett; Mark C Grier; Atul K Verma; Gabriel Medjanis; Janice E Donatelli; Ann B Macone; S Ken Tanaka; Stuart B Levy; Michael N Alekshun
N-hydroxybenzimidazole inhibitors of the transcription factor LcrF in Yersinia: novel antivirulence agents.
Journal of medicinal chemistry 2009;52(18):5626-34.
2009: Mark W Silby; Julie S Nicoll; Stuart B Levy
Requirement of polyphosphate by Pseudomonas fluorescens Pf0-1 for competitive fitness and heat tolerance in laboratory media and sterile soil.
Applied and environmental microbiology 2009;75(12):3872-81.
2009: Wook Kim; Mark W Silby; Sam O Purvine; Julie S Nicoll; Kim K Hixson; Matt Monroe; Carrie D Nicora; Mary S Lipton; Stuart B Levy
Proteomic detection of non-annotated protein-coding genes in Pseudomonas fluorescens Pf0-1.
PloS one 2009;4(12):e8455.
2008: Mark W Silby; Stuart B Levy
Overlapping protein-encoding genes in Pseudomonas fluorescens Pf0-1.
PLoS genetics 2008;4(6):e1000094.
2008: Wook Kim; Stuart B Levy
Increased fitness of Pseudomonas fluorescens Pf0-1 leucine auxotrophs in soil.
Applied and environmental microbiology 2008;74(12):3644-51.
2008: Cristian Ruiz; Laura M McMurry; Stuart B Levy
Role of the multidrug resistance regulator MarA in global regulation of the hdeAB acid resistance operon in Escherichia coli.
Journal of bacteriology 2008;190(4):1290-7.
2008: Patrick F McDermott; Laura M McMurry; Isabelle Podglajen; JoAnn Dzink-Fox; Thamarai Schneiders; Michael P Draper; Stuart B Levy
The marC gene of Escherichia coli is not involved in multiple antibiotic resistance.
Antimicrobial agents and chemotherapy 2008;52(1):382-3.
2007: Todd E Bowser; Victoria J Bartlett; Mark C Grier; Atul K Verma; Taduesz Warchol; Stuart B Levy; Michael N Alekshun
Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors.
Bioorganic & medicinal chemistry letters 2007;17(20):5652-5.
2007: Francis Domain; Xiaowen R Bina; Stuart B Levy
Transketolase A, an enzyme in central metabolism, derepresses the marRAB multiple antibiotic resistance operon of Escherichia coli by interaction with MarR.
Molecular microbiology 2007;66(2):383-94.
2007: Frédéric M Sapunaric; Stuart B Levy
Interdomain loop mutation Asp190Cys of the tetracycline efflux transporter TetA(B) decreases affinity for substrate.
Antimicrobial agents and chemotherapy 2007;51(8):3036-7.
2007: Hervé Nicoloff; Vincent Perreten; Stuart B Levy
Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple-antibiotic-resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications.
Antimicrobial agents and chemotherapy 2007;51(4):1293-303.
2007: Michael N Alekshun; Stuart B Levy
Molecular mechanisms of antibacterial multidrug resistance.
Cell 2007;128(6):1037-50.
2006: Paul Casaz; Lynne K Garrity-Ryan; David McKenney; Caroline Jackson; Stuart B Levy; S Ken Tanaka; Michael N Alekshun
MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis.
Microbiology (Reading, England) 2006;152(Pt 12):3643-50.
2006: Rupa A Udani; Stuart B Levy
MarA-like regulator of multidrug resistance in Yersinia pestis.
Antimicrobial agents and chemotherapy 2006;50(9):2971-5.
2006: Hervé Nicoloff; Vincent Perreten; Laura M McMurry; Stuart B Levy
Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB.
Journal of bacteriology 2006;188(12):4413-23.
2006: Thamarai Schneiders; Stuart B Levy
MarA-mediated transcriptional repression of the rob promoter.
The Journal of biological chemistry 2006;281(15):10049-55.
2006: Michael N Alekshun; Stuart B Levy
Commensals upon us.
Biochemical pharmacology 2006;71(7):893-900.
2006: Steven Ades; Lori F Maxfield; Christopher J Gould; Graham K Jones; Stuart B Levy
Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors.
International journal of oncology 2006;28(3):747-53.
2005: Stuart B Levy
Antibiotic resistance-the problem intensifies.
Advanced drug delivery reviews 2005;57(10):1446-50.
2005: Frédéric M Sapunaric; Stuart B Levy
Substitutions in the interdomain loop of the Tn10 TetA efflux transporter alter tetracycline resistance and substrate specificity.
Microbiology (Reading, England) 2005;151(Pt 7):2315-22.
2005: Stuart B Levy; Laura M McMurry; Marilyn C Roberts
Tet protein hybrids.
Antimicrobial agents and chemotherapy 2005;49(7):3099.
2004: Stuart B Levy; Bonnie Marshall
Antibacterial resistance worldwide: causes, challenges and responses.
Nature medicine 2004;10(12 Suppl):S122-9.
2004: Mark W Silby; Stuart B Levy
Use of in vivo expression technology to identify genes important in growth and survival of Pseudomonas fluorescens Pf0-1 in soil: discovery of expressed sequences with novel genetic organization.
Journal of bacteriology 2004;186(21):7411-9.
2004: Thamarai Schneiders; Teresa M Barbosa; Laura M McMurry; Stuart B Levy
The Escherichia coli transcriptional regulator MarA directly represses transcription of purA and hdeA.
The Journal of biological chemistry 2004;279(10):9037-42.
2004: Mark W Silby; Paul B Rainey; Stuart B Levy
IVET experiments in Pseudomonas fluorescens reveal cryptic promoters at loci associated with recognizable overlapping genes.
Microbiology (Reading, England) 2004;150(Pt 3):518-20.
2003: Thamarai Schneiders; S G B Amyes; Stuart B Levy
Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore.
Antimicrobial agents and chemotherapy 2003;47(9):2831-7.
2003: Frédéric M Sapunaric; Stuart B Levy
Second-site suppressor mutations for the serine 202 to phenylalanine substitution within the interdomain loop of the tetracycline efflux protein Tet(C).
The Journal of biological chemistry 2003;278(31):28588-92.
2003: Mark L Nelson; Mohamed Y Ismail; Laura McIntyre; Beena Bhatia; Peter Viski; Paul Hawkins; Glen Rennie; David Andorsky; David Messersmith; Karen Stapleton; Jimmy Dumornay; Paul Sheahan; Atul K Verma; Tadeusz Warchol; Stuart B Levy
Versatile and facile synthesis of diverse semisynthetic tetracycline derivatives via Pd-catalyzed reactions.
The Journal of organic chemistry 2003;68(15):5838-51.
2003: Xiaowen R Bina; Vincent Perreten; Stuart B Levy
The periplasmic protein MppA requires an additional mutated locus to repress marA expression in Escherichia coli.
Journal of bacteriology 2003;185(4):1465-9.
2003: Eduardo A Robleto; Inmaculada López-Hernández; Mark W Silby; Stuart B Levy
Genetic analysis of the AdnA regulon in Pseudomonas fluorescens: nonessential role of flagella in adhesion to sand and biofilm formation.
Journal of bacteriology 2003;185(2):453-60.
2002: Laura M McMurry; Mila L Aldema-Ramos; Stuart B Levy
Fe(2+)-tetracycline-mediated cleavage of the Tn10 tetracycline efflux protein TetA reveals a substrate binding site near glutamine 225 in transmembrane helix 7.
Journal of bacteriology 2002;184(18):5113-20.
2002: Teresa M Barbosa; Stuart B Levy
Activation of the Escherichia coli nfnB gene by MarA through a highly divergent marbox in a class II promoter.
Molecular microbiology 2002;45(1):191-202.
2002: Stuart B Levy
The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance.
The Journal of antimicrobial chemotherapy 2002;49(1):25-30.
2001: Michael N Alekshun; Stuart B Levy; Tanya R Mealy; Barbara A Seaton; James F Head
The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution.
Nature structural biology 2001;8(8):710-4.
2001: Hui Wang; JoAnn Dzink-Fox; Minjun Chen; Stuart B Levy
Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.
Antimicrobial agents and chemotherapy 2001;45(5):1515-21.
2001: Vincent Perreten; F V Schwarz; Michael Teuber; Stuart B Levy
Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli.
Antimicrobial agents and chemotherapy 2001;45(4):1109-14.
2001: Paul Casaz; A Happel; J Keithan; D L Read; S R Strain; Stuart B Levy
The Pseudomonas fluorescens transcription activator AdnA is required for adhesion and motility.
Microbiology (Reading, England) 2001;147(Pt 2):355-61.
2001: B Marshall; Eduardo A Robleto; R Wetzler; P Kulle; Paul Casaz; Stuart B Levy
The adnA transcriptional factor affects persistence and spread of Pseudomonas fluorescens under natural field conditions.
Applied and environmental microbiology 2001;67(2):852-7.
2000: C A Saraceni-Richards; Stuart B Levy
Second-site suppressor mutations of inactivating substitutions at gly247 of the tetracycline efflux protein, Tet(B).
Journal of bacteriology 2000;182(22):6514-6.
2000: R S Wong; Laura M McMurry; Stuart B Levy
'Intergenic' blr gene in Escherichia coli encodes a 41-residue membrane protein affecting intrinsic susceptibility to certain inhibitors of peptidoglycan synthesis.
Molecular microbiology 2000;37(2):364-70.
2000: Teresa M Barbosa; Stuart B Levy
Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA.
Journal of bacteriology 2000;182(12):3467-74.
2000: Winfried V Kern; M Oethinger; AS Jellen-Ritter; Stuart B Levy
Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.
Antimicrobial agents and chemotherapy 2000;44(4):814-20.
2000: C A Saraceni-Richards; Stuart B Levy
Evidence for interactions between helices 5 and 8 and a role for the interdomain loop in tetracycline resistance mediated by hybrid Tet proteins.
The Journal of biological chemistry 2000;275(9):6101-6.
2000: Michael N Alekshun; Y S Kim; Stuart B Levy
Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding.
Molecular microbiology 2000;35(6):1394-404.
2000: M Oethinger; Winfried V Kern; AS Jellen-Ritter; Laura M McMurry; Stuart B Levy
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.
Antimicrobial agents and chemotherapy 2000;44(1):10-3.
1999: Michael N Alekshun; Stuart B Levy
The mar regulon: multiple resistance to antibiotics and other toxic chemicals.
Trends in microbiology 1999;7(10):410-3.
1999: Michael N Alekshun; Stuart B Levy
Alteration of the repressor activity of MarR, the negative regulator of the Escherichia coli marRAB locus, by multiple chemicals in vitro.
Journal of bacteriology 1999;181(15):4669-72.
1999: M L Nelson; Stuart B Levy
Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein.
Antimicrobial agents and chemotherapy 1999;43(7):1719-24.
1999: Stuart B Levy; Laura M McMurry; Teresa M Barbosa; V Burdett; P Courvalin; Wolfgang Hillen; M C Roberts; Julian I Rood; D E Taylor
Nomenclature for new tetracycline resistance determinants.
Antimicrobial agents and chemotherapy 1999;43(6):1523-4.
1999: Michael N Alekshun; Stuart B Levy
Characterization of MarR superrepressor mutants.
Journal of bacteriology 1999;181(10):3303-6.
1999: Laura M McMurry; Patrick F McDermott; Stuart B Levy
Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan.
Antimicrobial agents and chemotherapy 1999;43(3):711-3.
1998: Laura M McMurry; Stuart B Levy
Revised sequence of OtrB (tet347) tetracycline efflux protein from Streptomyces rimosus.
Antimicrobial agents and chemotherapy 1998;42(11):3050.
1998: Laura M McMurry; M Oethinger; Stuart B Levy
Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli.
FEMS microbiology letters 1998;166(2):305-9.
1998: Laura M McMurry; M Oethinger; Stuart B Levy
Triclosan targets lipid synthesis.
Nature 1998;394(6693):531-2.
1998: M Oethinger; Isabelle Podglajen; Winfried V Kern; Stuart B Levy
Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.
Antimicrobial agents and chemotherapy 1998;42(8):2089-94.
1998: Patrick F McDermott; D G White; Isabelle Podglajen; Michael N Alekshun; Stuart B Levy
Multidrug resistance following expression of the Escherichia coli marA gene in Mycobacterium smegmatis.
Journal of bacteriology 1998;180(11):2995-8.
1998: Stuart B Levy
The challenge of antibiotic resistance.
Scientific American 1998;278(3):46-53.
1998: Stuart B Levy; M Nelson
Reversing tetracycline resistance. A renaissance for the tetracycline family of antibiotics.
Advances in experimental medicine and biology 1998;456():17-25.
1998: M Oethinger; Winfried V Kern; J D Goldman; Stuart B Levy
Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli.
The Journal of antimicrobial chemotherapy 1998;41(1):111-4.
1997: D E Modrak; MP Draper; Stuart B Levy
Emergence of different mechanisms of resistance in the evolution of multidrug resistance in murine erythroleukemia cell lines.
Biochemical pharmacology 1997;54(12):1297-306.
1997: M C Moken; Laura M McMurry; Stuart B Levy
Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci.
Antimicrobial agents and chemotherapy 1997;41(12):2770-2.
1997: D G White; K Maneewannakul; E von Hofe; M Zillman; W Eisenberg; A K Field; Stuart B Levy
Inhibition of the multiple antibiotic resistance (mar) operon in Escherichia coli by antisense DNA analogs.
Antimicrobial agents and chemotherapy 1997;41(12):2699-704.
1997: Ruth M Kennan; Laura M McMurry; Stuart B Levy; Julian I Rood
Glutamate residues located within putative transmembrane helices are essential for TetA(P)-mediated tetracycline efflux.
Journal of bacteriology 1997;179(22):7011-5.
1997: Michael N Alekshun; Stuart B Levy
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon.
Antimicrobial agents and chemotherapy 1997;41(10):2067-75.
1997: D G White; J D Goldman; B Demple; Stuart B Levy
Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli.
Journal of bacteriology 1997;179(19):6122-6.
1997: MP Draper; RL Martell; Stuart B Levy
Active efflux of the free acid form of the fluorescent dye 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein in multidrug-resistance-protein-overexpressing murine and human leukemia cells.
European journal of biochemistry / FEBS 1997;243(1-2):219-24.
1997: Paula M Fracasso; Christopher A Slapak; S Nair; D Modrak; M P Draper; J M LeCerf; Stuart B Levy
Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.
Oncology research 1997;9(4):183-91.
1997: MP Draper; RL Martell; Stuart B Levy
Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
British journal of cancer 1997;75(6):810-5.
1997: RL Martell; Christopher A Slapak; Stuart B Levy
Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3.
British journal of cancer 1997;75(2):161-8.
1996: Christopher A Slapak; R L Martell; M Terashima; Stuart B Levy
Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP).
Biochemical pharmacology 1996;52(10):1569-76.
1996: K Maneewannakul; Stuart B Levy
Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli.
Antimicrobial agents and chemotherapy 1996;40(7):1695-8.
1996: J D Goldman; D G White; Stuart B Levy
Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones.
Antimicrobial agents and chemotherapy 1996;40(5):1266-9.
1996: M L Aldema; Laura M McMurry; A R Walmsley; Stuart B Levy
Purification of the Tn10-specified tetracycline efflux antiporter TetA in a native state as a polyhistidine fusion protein.
Molecular microbiology 1996;19(1):187-95.
1995: Laura M McMurry; Stuart B Levy
The NH2-terminal half of the Tn10-specified tetracycline efflux protein TetA contains a dimerization domain.
The Journal of biological chemistry 1995;270(39):22752-7.
1995: A S Seoane; Stuart B Levy
Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli.
Journal of bacteriology 1995;177(12):3414-9.
1995: A S Seoane; Stuart B Levy
Identification of new genes regulated by the marRAB operon in Escherichia coli.
Journal of bacteriology 1995;177(3):530-5.
1995: Stuart B Levy
Antimicrobial resistance: a global perspective.
Advances in experimental medicine and biology 1995;390():1-13.
1994: Christopher A Slapak; P M Fracasso; R L Martell; D L Toppmeyer; J M Lecerf; Stuart B Levy
Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Cancer research 1994;54(21):5607-13.
1994: Stuart B Levy
Balancing the drug-resistance equation.
Trends in microbiology 1994;2(10):341-2.
1994: M F Deflaun; B M Marshall; E P Kulle; Stuart B Levy
Tn5 Insertion Mutants of Pseudomonas fluorescens Defective in Adhesion to Soil and Seeds.
Applied and environmental microbiology 1994;60(7):2637-42.
1994: M L Nelson; B H Park; Stuart B Levy
Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria.
Journal of medicinal chemistry 1994;37(9):1355-61.
1994: Laura M McMurry; A M George; Stuart B Levy
Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutants.
Antimicrobial agents and chemotherapy 1994;38(3):542-6.
1994: Joan Sloan; Laura M McMurry; Dena Lyras; Stuart B Levy; Julian I Rood
The Clostridium perfringens Tet P determinant comprises two overlapping genes: tetA(P), which mediates active tetracycline efflux, and tetB(P), which is related to the ribosomal protection family of tetracycline-resistance determinants.
Molecular microbiology 1994;11(2):403-15.
1993: S P Cohen; Stuart B Levy; J Foulds; Judah L Rosner
Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway.
Journal of bacteriology 1993;175(24):7856-62.
1993: S P Cohen; W Yan; Stuart B Levy
A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria.
The Journal of infectious diseases 1993;168(2):484-8.
1993: S P Cohen; Herbert Hächler; Stuart B Levy
Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli.
Journal of bacteriology 1993;175(5):1484-92.
1993: M L Nelson; B H Park; J S Andrews; V A Georgian; R C Thomas; Stuart B Levy
Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.
Journal of medicinal chemistry 1993;36(3):370-7.
1992: A Seoane; Alfredo Sabbaj; Laura M McMurry; Stuart B Levy
Multiple antibiotic susceptibility associated with inactivation of the prc gene.
Journal of bacteriology 1992;174(23):7844-7.
1992: Laura M McMurry; M Stephan; Stuart B Levy
Decreased function of the class B tetracycline efflux protein Tet with mutations at aspartate 15, a putative intramembrane residue.
Journal of bacteriology 1992;174(19):6294-7.
1992: Christopher A Slapak; J M Lecerf; J C Daniel; Stuart B Levy
Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.
The Journal of biological chemistry 1992;267(15):10638-44.
1992: Stuart B Levy
Active efflux mechanisms for antimicrobial resistance.
Antimicrobial agents and chemotherapy 1992;36(4):695-703.
1991: Herbert Hächler; S P Cohen; Stuart B Levy
marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli.
Journal of bacteriology 1991;173(17):5532-8.
1991: R A Rubin; Stuart B Levy
Tet protein domains interact productively to mediate tetracycline resistance when present on separate polypeptides.
Journal of bacteriology 1991;173(14):4503-9.
1990: Christopher A Slapak; J C Daniel; Stuart B Levy
Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
Cancer research 1990;50(24):7895-901.
1990: B Marshall; D Petrowski; Stuart B Levy
Inter- and intraspecies spread of Escherichia coli in a farm environment in the absence of antibiotic usage.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(17):6609-13.
1990: Robert Hickman; Laura M McMurry; Stuart B Levy
Overproduction and purification of the Tn10-specified inner membrane tetracycline resistance protein Tet using fusions to beta-galactosidase.
Molecular microbiology 1990;4(8):1241-51.
1990: R A Rubin; Stuart B Levy
Interdomain hybrid Tet proteins confer tetracycline resistance only when they are derived from closely related members of the tet gene family.
Journal of bacteriology 1990;172(5):2303-12.
1990: R A Rubin; Stuart B Levy; R L Heinrikson; F J Kézdy
Gene duplication in the evolution of the two complementing domains of gram-negative bacterial tetracycline efflux proteins.
Gene 1990;87(1):7-13.
1990: M F Deflaun; A S Tanzer; A L McAteer; B Marshall; Stuart B Levy
Development of an Adhesion Assay and Characterization of an Adhesion-Deficient Mutant of Pseudomonas fluorescens.
Applied and environmental microbiology 1990;56(1):112-9.
1989: Stuart B Levy; Laura M McMurry; V Burdett; P Courvalin; Wolfgang Hillen; M C Roberts; D E Taylor
Nomenclature for tetracycline resistance determinants.
Antimicrobial agents and chemotherapy 1989;33(8):1373-4.
1989: S P Cohen; Laura M McMurry; David C Hooper; J S Wolfson; Stuart B Levy
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
Antimicrobial agents and chemotherapy 1989;33(8):1318-25.
1989: K E Leonardson; Stuart B Levy
Chromatin reorganization during emergence of malignant Friend tumors: early changes in H2A and H2B variants and nucleosome repeat length.
Experimental cell research 1989;180(1):209-19.
1988: Stuart B Levy; B Marshall; S Schluederberg; D Rowse; J Davis
High frequency of antimicrobial resistance in human fecal flora.
Antimicrobial agents and chemotherapy 1988;32(12):1801-6.
1988: B H Park; Stuart B Levy
The cryptic tetracycline resistance determinant on Tn4400 mediates tetracycline degradation as well as tetracycline efflux.
Antimicrobial agents and chemotherapy 1988;32(12):1797-800.
1988: S P Cohen; Laura M McMurry; Stuart B Levy
marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli.
Journal of bacteriology 1988;170(12):5416-22.
1988: P De Togni; E S Fox; S Morrissey; B M Babior; Stuart B Levy
Spontaneous insertion of an IS2 element into the promoter region of the lac operon.
Plasmid 1988;20(2):143-7.
1988: S P Cohen; David C Hooper; J S Wolfson; K S Souza; Laura M McMurry; Stuart B Levy
Endogenous active efflux of norfloxacin in susceptible Escherichia coli.
Antimicrobial agents and chemotherapy 1988;32(8):1187-91.
1988: Robert Hickman; Stuart B Levy
Evidence that TET protein functions as a multimer in the inner membrane of Escherichia coli.
Journal of bacteriology 1988;170(4):1715-20.
1987: B H Park; M Hendricks; M H Malamy; F P Tally; Stuart B Levy
Cryptic tetracycline resistance determinant (class F) from Bacteroides fragilis mediates resistance in Escherichia coli by actively reducing tetracycline accumulation.
Antimicrobial agents and chemotherapy 1987;31(11):1739-43.
1987: Laura M McMurry; B H Park; V Burdett; Stuart B Levy
Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci.
Antimicrobial agents and chemotherapy 1987;31(10):1648-50.
1983: B Marshall; C Tachibana; Stuart B Levy
Frequency of tetracycline resistance determinant classes among lactose-fermenting coliforms.
Antimicrobial agents and chemotherapy 1983;24(6):835-40.
1981: B Marshall; S Schluederberg; C Tachibana; Stuart B Levy
Survival and transfer in the human gut of poorly mobilizable (pBR322) and of transferable plasmids from the same carrier E. coli.
Gene 1981;14(3):145-54.
1980: S A Schluederberg; B Marshall; C Tachibana; Stuart B Levy
Recovery frequency of phages lambda and M13 from human and animal faeces.
Nature 1980;283(5749):792-4.